Literature DB >> 10882665

Comparison of a monoclonal antibody-blocking enzyme-linked immunoassay and a strip immunoblot assay for identifying type-specific herpes simplex virus type 2 serological responses.

G J Van Doornum1, M J Slomka, M Buimer, J Groen, J A Van den Hoek, I Cairo, A Vyse, D W Brown.   

Abstract

Detection of herpes simplex virus type 2 (HSV-2)-specific antibodies by a monoclonal antibody (MAb)-blocking enzyme-linked immunoassay (EIA) was compared with detection by a strip immunoblot assay (SIA) in a sexually transmitted disease (STD) clinic population. The study population consisted of 1,683 genitourinary medicine clinic attendees (582 women and 1,101 men). Sera were tested for the presence of HSV-2 antibody by use of the blocking EIA, in which binding of the MAb AP-1 to HSV-2 glycoprotein G-2 (gG-2) is blocked by HSV-2-specific antibody. The Chiron RIBA HSV-1 and -2 strip immunoassay (SIA) utilizes HSV-1- and HSV-2-specific or cross-reactive antigens immobilized on nitrocellulose strips (HSV gB-1 and HSV gG-1 peptide bands specific for HSV-1 antibody, HSV-2 gG-2 band specific for HSV-2 antibody, and HSV gD-2 band cross-reactive for HSV-1 and HSV-2 antibodies). A total of 1,612 sera were tested by MAb-blocking EIA for HSV-2 antibody and by SIA for HSV-1 and HSV-2 antibodies. By EIA, 541 (33.6%) sera were positive for HSV-2 antibody and 1,068 sera were negative for HSV-2 antibody; 3 sera gave equivocal results. HSV-2 antibody was detected in 555 (34.4%) sera by SIA; 144 (26%) of these sera possessed only HSV-2 antibody, and 411 (74%) sera contained both HSV-1 and HSV-2 antibodies. SIA detected HSV-1 antibody in 1,155 (71.6%) sera; 744 (64%) of these sera contained HSV-1 antibody alone. Sixteen sera contained antibody against HSV but could not be typed by SIA. A total of 512 sera were positive for HSV-2 antibody by both the EIA and SIA. We concluded that the blocking EIA and SIA showed a high level of agreement in detecting HSV-2 antibody in this population. In contrast to the SIA, the blocking EIA is a useful tool for large epidemiological studies, though the SIA proved to be slightly more sensitive once sera with discrepant results were further tested.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10882665      PMCID: PMC95927          DOI: 10.1128/CDLI.7.4.641-644.2000

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  32 in total

1.  Escherichia coli expressed herpes simplex virus gG1 and gG2 proteins in ELISA and immunoblotting assays.

Authors:  A Kakkanas; H Papadogeorgaki; R Manservigi; V Miriagou; U Georgopoulou; P Mavromara
Journal:  Intervirology       Date:  1995       Impact factor: 1.763

2.  Comparison of a direct antigen enzyme immunoassay, Herpchek, with cell culture for detection of herpes simplex virus from clinical specimens.

Authors:  L Verano; F J Michalski
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

3.  Underestimation of HSV-2 seroprevalence in a high-risk population by microneutralization assay.

Authors:  R L Ashley; J Dalessio; J Dragavon; L A Koutsky; F K Lee; A J Nahmias; C E Stevens; K K Holmes; L Corey
Journal:  Sex Transm Dis       Date:  1993 Jul-Aug       Impact factor: 2.830

Review 4.  Laboratory techniques in the diagnosis of herpes simplex infection.

Authors:  R L Ashley
Journal:  Genitourin Med       Date:  1993-06

5.  Relationship between antibodies to herpes simplex virus (HSV) and symptoms of HSV infection.

Authors:  F M Cowan; A M Johnson; R Ashley; L Corey; A Mindel
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

6.  Peptide sequences of glycoprotein G-2 discriminate between herpes simplex virus type 2 (HSV-2) and HSV-1 antibodies.

Authors:  M Levi; U Rudén; B Wahren
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

7.  Virologic characteristics of subclinical and symptomatic genital herpes infections.

Authors:  A Wald; J Zeh; S Selke; R L Ashley; L Corey
Journal:  N Engl J Med       Date:  1995-09-21       Impact factor: 91.245

Review 8.  Seroepidemiology and control of genital herpes: the value of type specific antibodies to herpes simplex virus.

Authors:  M J Slomka
Journal:  Commun Dis Rep CDR Rev       Date:  1996-03-01

9.  Monoclonal antibody blocking tests for the detection of HSV-1- and HSV-2-specific humoral responses: comparison with western blot assay.

Authors:  M J Slomka; R L Ashley; F M Cowan; A Cross; D W Brown
Journal:  J Virol Methods       Date:  1995-09       Impact factor: 2.014

10.  Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations.

Authors:  F M Cowan; A M Johnson; R Ashley; L Corey; A Mindel
Journal:  BMJ       Date:  1994-11-19
View more
  4 in total

1.  Novel approach for specific detection of herpes simplex virus type 1 and 2 antibodies and immunoglobulin G and M antibodies.

Authors:  B Ohana; M Lipson; N Vered; I Srugo; M Ahdut; A Morag
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

2.  Evaluation of the HerpeSelect Express rapid test in the detection of herpes simplex virus type 2 antibodies in patients with genital ulcer disease.

Authors:  Hani Al-Shobaili; Khaled M Hassanein; Marwa Salah Mostafa; Ali Saleh Al Duways
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

3.  Prevalence and risk factors of HSV-1 and HSV-2 antibodies in European HIV infected women.

Authors:  B H van Benthem; J Spaargaren; J A van Den Hoek; J Merks; R A Coutinho; M Prins
Journal:  Sex Transm Infect       Date:  2001-04       Impact factor: 3.519

4.  Herpes simplex virus type 1 in Europe: systematic review, meta-analyses and meta-regressions.

Authors:  Wajiha Yousuf; Hania Ibrahim; Manale Harfouche; Farah Abu Hijleh; Laith Abu-Raddad
Journal:  BMJ Glob Health       Date:  2020-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.